Doherty; Annette Marian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doherty; Annette Marian.The latest application filed is for "4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors".

Company Profile

0.22.10

Doherty; Annette Marian - Paris FR
Doherty; Annette Marian - Nr Canterbury GB
Doherty; Annette Marian - Ann Arbor MI
Doherty; Annette Marian - Anthony FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases Grant 7,786,131 - Bridges , et al. August 31, 2	2010-08-31
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors Grant 7,169,816 - Barrett , et al. January 30, 2	2007-01-30
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives Grant 7,019,033 - Barrett , et al. March 28, 2	2006-03-28
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20060052608 - Barrett; Stephen Douglas ; et al.	2006-03-09
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20050049429 - Barrett, Stephen Douglas ; et al.	2005-03-03
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors Grant 6,821,963 - Barrett , et al. November 23, 2	2004-11-23
Inhibitors of protein farnesyl transferase Grant 6,737,410 - Doherty , et al. May 18, 2	2004-05-18
Irreversible inhibitors of tyrosine kinases App 20030229051 - Bridges, Alexander James ; et al.	2003-12-11
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives App 20030149015 - Barrett, Stephen Douglas ; et al.	2003-08-07
Irreversible inhibitors of tyrosine kinases Grant 6,602,863 - Bridges , et al. August 5, 2	2003-08-05
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20030078428 - Barrett, Stephen Douglas ; et al.	2003-04-24
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20030073684 - Bunker, Amy Mae ; et al.	2003-04-17
Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation Grant 6,498,163 - Boschelli , et al. December 24, 2	2002-12-24
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20020094980 - Bunker, Amy Mae ; et al.	2002-07-18
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives App 20020022647 - Barrett, Stephen Douglas ; et al.	2002-02-21
Irreversible inhibitors of tyrosine kinases Grant 6,344,459 - Bridges , et al. Fe	2002-02-05
Bicyclic inhibitors of protein farnesyl transferase App 20020006936 - Bikker, Jack ; et al.	2002-01-17
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20010036944 - Bunker, Amy Mae ; et al.	2001-11-01
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors Grant 6,310,060 - Barrett , et al. October 30, 2	2001-10-30
Method of treating or preventing septic shock by administering a MEK inhibitor Grant 6,251,943 - Barrett , et al. June 26, 2	2001-06-26
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation Grant 6,218,388 - Boschelli , et al. April 17, 2	2001-04-17
Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use Grant 6,136,798 - Cody , et al. October 24, 2	2000-10-24
Bicyclic inhibitors of protein farnesyl transferase Grant 6,133,303 - Bikker , et al. October 17, 2	2000-10-17
Low molecular weight bicyclic thrombin inhibitors Grant 6,057,314 - Dimaio , et al. May 2, 2	2000-05-02
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation Grant 5,990,146 - Boschelli , et al. November 23, 1	1999-11-23
6-aryl naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation Grant 5,952,342 - Blankley , et al. September 14, 1	1999-09-14
6-Aryl pyrido[2,3-d] pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation Grant 5,733,913 - Blankley , et al. March 31, 1	1998-03-31
Pyrido[2, 3-d]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation Grant 5,733,914 - Blankley , et al. March 31, 1	1998-03-31
Hydroxamate inhibitors of endothelin converting enzyme Grant 5,663,296 - Doherty , et al. September 2, 1	1997-09-02
Phenylalanine derivatives as endothelin antagonists Grant 5,658,943 - Berryman , et al. August 19, 1	1997-08-19
Quinazolines as inhibitors of endothelin converting enzyme Grant 5,658,902 - Ahn , et al. August 19, 1	1997-08-19
Methods of using endothelin antagonists Grant 5,641,752 - Cody , et al. June 24, 1	1997-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.